These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29196963)

  • 21. Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study.
    Smith MR; Malkowicz SB; Chu F; Forrest J; Sieber P; Barnette KG; Rodriquez D; Steiner MS
    J Clin Oncol; 2008 Apr; 26(11):1824-9. PubMed ID: 18398147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.
    Wasan KM; Goss PE; Pritchard PH; Shepherd L; Tu D; Ingle JN
    Breast Cancer Res Treat; 2012 Dec; 136(3):769-76. PubMed ID: 23089983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of 1-year treatment with raloxifene on bone and lipid metabolism in Japanese postmenopausal women with osteoporosis.
    Majima T; Komatsu Y; Shimatsu A; Satoh N; Fukao A; Ninomiya K; Matsumura T; Nakao K
    Endocr J; 2007 Dec; 54(6):855-62. PubMed ID: 17917307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Follicle-Stimulating Hormone and Estradiol Levels in Japanese Women Treated with Toremifene and Anastrozole for Two Years - A Retrospective Analysis of Data from a Prospective Randomized Trial].
    Anan K; Mitsuyama S; Yanagita Y; Kimura M; Doihara H; Komaki K; Kusama M; Ikeda T
    Gan To Kagaku Ryoho; 2018 Dec; 45(12):1725-1728. PubMed ID: 30587728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of effects of tamoxifen and Toremifene on hepatic function and serum lipids in breast cancer patients during adjuvant endocrine therapy.
    Wang W; Liu X
    Anticancer Drugs; 2024 Apr; 35(4):371-376. PubMed ID: 38241197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer.
    Gylling H; Pyrhönen S; Mäntylä E; Mäenpää H; Kangas L; Miettinen TA
    J Clin Oncol; 1995 Dec; 13(12):2900-5. PubMed ID: 8523053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial.
    Chow LW; Yip AY; Chu WP; Loo WT; Toi M
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):112-9. PubMed ID: 21236344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover.
    Oesterreich S; Henry NL; Kidwell KM; Van Poznak CH; Skaar TC; Dantzer J; Li L; Hangartner TN; Peacock M; Nguyen AT; Rae JM; Desta Z; Philips S; Storniolo AM; Stearns V; Hayes DF; Flockhart DA
    Breast Cancer Res Treat; 2015 Nov; 154(2):263-73. PubMed ID: 26536870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
    Hernández E; Valera R; Alonzo E; Bajares-Lilue M; Carlini R; Capriles F; Martinis R; Bellorin-Font E; Weisinger JR
    Kidney Int; 2003 Jun; 63(6):2269-74. PubMed ID: 12753317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study.
    Balduzzi A; Bagnardi V; Sandri MT; Dellapasqua S; Cardillo A; Montagna E; Cancello G; Iorfida M; Ghisini R; Viale G; Intra M; Luini A; Goldhirsch A; Colleoni M
    Clin Breast Cancer; 2015 Oct; 15(5):e257-62. PubMed ID: 26362840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II clinical trial of high-dose toremifene as primary hormone therapy in aromatase inhibitor-resistant breast cancer.
    Ogata H; Okamoto Y; Arima Y; Fukushima H; Takeyama H; Yamashita A; Kinoshita M; Suzuki N; Sawada T; Koshida Y; Matsui A; Tachibana A; Nakayama H; Oishi Y; Nogi H; Uchida K
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):749-53. PubMed ID: 23863651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
    ; Thürlimann B; Keshaviah A; Coates AS; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Rabaglio M; Smith I; Wardley A; Price KN; Goldhirsch A
    N Engl J Med; 2005 Dec; 353(26):2747-57. PubMed ID: 16382061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer.
    Milla-Santos A; Milla L; Rallo L; Solano V
    Breast Cancer Res Treat; 2001 Jan; 65(2):119-24. PubMed ID: 11261827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost.
    Mäenpää JU; Ala-Fossi SL
    Drugs Aging; 1997 Oct; 11(4):261-70. PubMed ID: 9342556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences.
    Decensi A; Sun Z; Guerrieri-Gonzaga A; Thürlimann B; McIntosh C; Tondini C; Monnier A; Campone M; Debled M; Schönenberger A; Zaman K; Johansson H; Price KN; Gelber RD; Goldhirsch A; Coates AS; Aebi S
    Breast Cancer Res Treat; 2014 Apr; 144(2):321-9. PubMed ID: 24487691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-grade endometrial stromal sarcoma developing in a postmenopausal woman under toremifene treatment for breast cancer.
    Kashiyama T; Oda K; Kawana K; Arimoto T; Kanetaka Y; Takazawa Y; Maeda D; Nakagawa S; Yano T; Kozuma S
    J Obstet Gynaecol Res; 2013 Jan; 39(1):424-9. PubMed ID: 22690656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients.
    Ellmén J; Werner D; Hakulinen P; Keiling R; Fargeot P; Falkson G; Bezwoda WR
    Cancer Chemother Pharmacol; 2000; 45(5):402-8. PubMed ID: 10803924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant trials of toremifene vs tamoxifen: the European experience.
    Holli K
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):23-7. PubMed ID: 9556787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of letrozole on the lipid profile in postmenopausal women with breast cancer.
    Elisaf MS; Bairaktari ET; Nicolaides C; Kakaidi B; Tzallas CS; Katsaraki A; Pavlidis NA
    Eur J Cancer; 2001 Aug; 37(12):1510-3. PubMed ID: 11506958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
    Pyrhönen S; Valavaara R; Modig H; Pawlicki M; Pienkowski T; Gundersen S; Bauer J; Westman G; Lundgren S; Blanco G; Mella O; Nilsson I; Hietanen T; Hindy I; Vuorinen J; Hajba A
    Br J Cancer; 1997; 76(2):270-7. PubMed ID: 9231932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.